The Food and Drug Administration on Wednesday approved Eisai’s epilepsy drug Fyompa as a primary treatment for partial-onset seizures in epileptic patients 12 years or older. Here are three things to ...

Seizures can affect your daily life and well-being. Certain medicines can help lower the risk of having seizures, which can help manage your condition. Fycompa is a medicine used to manage ...

Vomiting 2.5 5.9 8.5 Vision blurred 2.5 2.2 8.5 Somnolence 4.7 5.2 8.1 Nasopharyngitis 5.8 6.3 7.6 Fatigue 5.8 7.0 7.2 Coordination abnormal 1.6 4.1 7.2 Tremor 4.1 3.7 6.2 Balance disorder 0.0 1.1 5.1 ...

Eisai Co., Ltd. has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa, (generic name perampanel) for use in the adjunctive treatment of partial-onset seizures (with or ...

Please provide your email address to receive an email when new articles are posted on . Fresenius Kabi announced the immediate availability of lacosamide injection, an approved treatment option for ...

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with ...

Anti-seizure medications, which are also called anticonvulsants or anti-epileptic drugs (AEDs), are medications used to prevent seizures for people who have epilepsy. All AEDs are available only by ...

Lacosamide 100mg, 150mg, 200mg; ext-rel caps. The precise mechanism by which Motpoly XR exerts its antiepileptic effects in humans remains to be fully elucidated. In vitro electrophysiological studies ...

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic drug (AED) ...

Austin Manes and Nicholas Tonckens of Kramer Levin Naftalis & Frankel LLP discuss privacy and cybersecurity policy under the Trump administration, looking at new leadership of key agencies.